BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Sean McCarthy is participating in a panel at the Financing Solutions and Strategies for Life Sciences Conference in New York City
News | 10. 19. 2009
